Not applicableStudy completedNCT00429910What this trial is testingNatural History Study of Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia Dana-Farber Cancer Institute 48
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Testing effectiveness (Phase 2)Study completedNCT01789255What this trial is testingVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00005064What this trial is testingPS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeWho this might be right forAdult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00627666What this trial is testingDonor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Asan Medical Center 52
Early research (Phase 1)Looking for participantsNCT04260022What this trial is testingStudy of HQP1351 in Subjects With Refractory CML and Ph+ ALLWho this might be right forLeukemia, Myeloid, ChronicMyeloid LeukemiaChronic Myeloid Leukemia+2 more Ascentage Pharma Group Inc. 242
Early research (Phase 1)Study completedNCT00002746What this trial is testingInterleukin-2 in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms University of Washington 24
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Ended earlyNCT00555048What this trial is testingAlemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 1
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT00387426What this trial is testingSunitinib in Treating Patients With Idiopathic MyelofibrosisWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+29 more National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00002504What this trial is testingInterleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Testing effectiveness (Phase 2)Study completedNCT00466726What this trial is testingVaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous LeukemiaWho this might be right forLeukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 57
Testing effectiveness (Phase 2)Ended earlyNCT00392782What this trial is testingDonor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other DiseaseWho this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 24
Early research (Phase 1)Ended earlyNCT00618696What this trial is testingYttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 4
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35